International PatientsNewsContact
HACETTEPE UNIVERSITYHOSPITALS
Appointment
EN
  1. Home
  2. Doctors
  3. Prof. Dr. Fatma Visal Okur
Prof. Dr. Fatma Visal Okur

Prof. Dr.

Fatma Visal Okur

Pediatric Hematology · Children's Hospital

Appointment

Publications

Source: Hacettepe University academic database (AVESİS) · All publications (88) ↗

Articles 38

  1. Pediatric Acute Transfusion Reactions: Diagnostic Pitfalls and Emerging MechanismsÖZDEMİRAL C., Aytekin E. S., KUŞKONMAZ B. B., OKUR F. V., ÇAĞDAŞ AYVAZ D. N., ŞEKEREL B. E.Asthma Allergy Immunology, cilt.24, sa.1, ss.26-32, 2026 (ESCI, Scopus, TRDizin)
  2. National Perspectives on Academic CAR-T Cell Therapy in Türkiye: A Report from the Turkish Society of Hematology’s Scientific Subcommittee on Cell and Gene Therapies (TSH-CGT SSC) Türkiye’de Akademik CAR-T Hücre Tedavisine İlişkin Ulusal Perspektifler: Türk Hematoloji Derneği, Hücre ve Gen Tedavileri Bilimsel Alt Komitesi (TSH-CGT SSC) RaporuYÜKSEL M., Yalçın K., ELVERDİ T., Yeral M., Soyer N. A., AKI Ş. Z., et al.Turkish Journal of Hematology, cilt.43, sa.3, ss.274-279, 2026 (SCI-Expanded, Scopus, TRDizin)
  3. Ciclosporin-related posterior reversible encephalopathy syndrome in a paediatric haematopoietic stem cell transplant recipientAKTAN M., YALÇIN N., Demirkan K., KUŞKONMAZ B. B., OKUR F. V., GÖÇMEN R.European Journal of Hospital Pharmacy, 2026 (SCI-Expanded, Scopus)
  4. Evidence of Stem Cell Entrapment in AN69 Membranes During Continuous Renal Replacement Therapy.Akbasli İ. T., Saritas Nakib O., Kesici S., Okur F. V., Gucer K. S., Bayrakci B.Artificial organs, cilt.49, ss.1327-1331, 2025 (SCI-Expanded, Scopus)
  5. Navigating Hope and Complexity: Turkish Parents' Experiences with Savior SiblingsEker I., Ozdemir H. N. c., Yilmaz F., Yesilipek A., Kupesiz A., Uygun V., et al.TURKISH JOURNAL OF HEMATOLOGY, cilt.42, sa.1, ss.47-55, 2025 (SCI-Expanded, Scopus, TRDizin)
  6. Late Effects Following Hematopoietic Stem Cell Transplantation Among Childhood Transplant Survivors with Fanconi AnemiaOzkocer C., Visal Okur F. V., Demirbilek H., Altintas B., Cetin N., Kuskonmaz B. B., et al.TURKISH JOURNAL OF HEMATOLOGY, cilt.42, sa.1, ss.15-24, 2025 (SCI-Expanded, Scopus, TRDizin)
  7. Calcineurin inhibitor-related hyperkalemia is caused by hyporeninemic hypoaldosteronism and fludrocortisone is an effective treatment: Report of a case series and review of the literatureÜNSAL Y., BALTU D., GÜLHAN B., OKUR F. V., ÖZALTIN F., DÜZOVA A., et al.PEDIATRIC TRANSPLANTATION, cilt.28, sa.4, 2024 (SCI-Expanded, Scopus)
  8. COVID-19 disease in children and adolescents following allogeneic hematopoietic stem cell transplantation: A report from the Turkish pediatric bone marrow transplantation study groupBozkurt C., Hazar V., Malbora B., Kupesiz A., Aygunes U., Fisgin T., et al.PEDIATRIC TRANSPLANTATION, cilt.28, sa.3, 2024 (SCI-Expanded, Scopus)
  9. Anti-human leukocyte antigen-DPB1 antibody-associated transfusion-related acute lung injury after hematopoietic stem cell infusionBALKAN M. C., OKUR F. V., Apak F. B. B., Babayeva S., EKİCİ N. F., KUŞKONMAZ B. B., et al.ASIAN JOURNAL OF TRANSFUSION SCIENCE, cilt.18, sa.1, ss.141-143, 2024 (ESCI, Scopus)
  10. Predictors of kidney complications and analysis of hypertension in children with allogeneic hematopoietic stem cell transplantationGurbanov A., GÜLHAN B., KUŞKONMAZ B. B., OKUR F. V., ÖZALTIN F., DÜZOVA A., et al.PEDIATRIC NEPHROLOGY, cilt.38, sa.2, ss.461-469, 2023 (SCI-Expanded, Scopus)
  11. First allogeneic hematopoietic stem cell transplantation in RASGRP1 deficiency: long-term follow-up.Kuskonmaz B. B., Ayvaz D. N., Okur F. V., Aydın B., Tezcan I., Uckan Cetinkaya D.Bone marrow transplantation, cilt.57, ss.1210-1212, 2022 (SCI-Expanded, Scopus)
  12. Thalassemia-free and graft-versus-host-free survival: outcomes of hematopoietic stem cell transplantation for thalassemia major, Turkish experienceYesilipek M. A., Uygun V., Kupesiz A., Karasu G., Ozturk G., ERTEM M., et al.BONE MARROW TRANSPLANTATION, cilt.57, sa.5, ss.760-767, 2022 (SCI-Expanded, Scopus)
  13. Alterations in Hematopoietic and Mesenchymal Stromal Cell Components of the Osteopetrotic Bone Marrow NicheZeytin I. C., Alkan B., ÖZDEMİR SAKA C., ÇETİNKAYA F. D., OKUR F. V.STEM CELLS TRANSLATIONAL MEDICINE, cilt.11, sa.3, ss.310-321, 2022 (SCI-Expanded, Scopus)
  14. Association of Pre-Transplant Angiopoietin-2 Index with the Risk of Acute Graft-Versus-Host Disease after Hematopoietic Stem Cell TransplantationŞATIRER Ö., Zeytin I. C., Alkan B., KARAKAYA KARABULUT J., ÇETİNKAYA F. D., OKUR F. V.TURKISH JOURNAL OF HEMATOLOGY, cilt.39, sa.1, ss.61-65, 2022 (SCI-Expanded, Scopus, TRDizin)
  15. Different Kinetics and Risk Factors for Isolated Extramedullary Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Children with Acute LeukemiaHazar V., Ozturk G., Yalcin K., Uygun V., AKSOYLAR S., Kupesiz A., et al.TRANSPLANTATION AND CELLULAR THERAPY, cilt.27, sa.10, 2021 (SCI-Expanded, Scopus)
  16. Fludrocortisone is the salvage treatment in cases with calcineurin inhibitor related hyperkalemiaUnsal Y., Baltu D., Gulhan B., Okur F. V., Duzova A., Ozon A., et al.HORMONE RESEARCH IN PAEDIATRICS, cilt.94, sa.SUPPL 1, ss.193-194, 2021 (SCI-Expanded, Scopus)
  17. Prognostic factors for survival in children who relapsed after allogeneic hematopoietic stem cell transplantation for acute leukemiaHazar V., Tezcan Karasu G., ozturk G., Kupesiz A., AKSOYLAR S., ozbek N., et al.PEDIATRIC TRANSPLANTATION, cilt.25, sa.5, 2021 (SCI-Expanded, Scopus)
  18. EARLY URINARY SYSTEM COMPLICATIONS IN CHILDREN WITH HEMATOPOETIC STEM CELL TRANSPLANTATIONGurbanov A., GÜLHAN B., KUŞKONMAZ B. B., OKUR F. V., ÇETİNKAYA F. D., Ozdemir G., et al.NEPHROLOGY DIALYSIS TRANSPLANTATION, cilt.36, 2021 (SCI-Expanded, Scopus)
  19. Pre-Conditioning Serum Uric Acid as a Risk Factor for Sinusoidal Obstruction Syndrome of the Liver in Children Undergoing Hematopoietic Stem Cell Transplantation Hematopoetik Kök Hücre Transplantasyonu Yapılan Çocuklarda Karaciğer Sinüzoidal Obstrüksiyon Sendromu için Bir Risk Faktörü Olarak Rejim Öncesi Serum Ürik Asit DüzeyiOKUR F. V., Karapapak M., Warasnhe K., ARSLAN U. E., KUŞKONMAZ B. B., Çetinkaya D.Turkish Journal of Hematology, cilt.38, sa.4, ss.286-293, 2021 (SCI-Expanded, Scopus, TRDizin)
  20. First Allogeneic Hematopoietic Stem Cell Transplantation in RASGRP1 DeficienyKUŞKONMAZ B. B., ÇAĞDAŞ AYVAZ D. N., OKUR F. V., Tezcan I., ÇETİNKAYA F. D.BONE MARROW TRANSPLANTATION, cilt.55, ss.653-654, 2020 (SCI-Expanded, Scopus)
  21. Role of a second transplantation for children with acute leukemia following posttransplantation relapse: a study by the Turkish Bone Marrow Transplantation Study GroupHazar V., Karasu G. T., Uygun V., Ozbek N., KARAKÜKCÜ M., Ozturk G., et al.LEUKEMIA & LYMPHOMA, cilt.61, sa.6, ss.1465-1474, 2020 (SCI-Expanded, Scopus)
  22. Evaluation of Drug-Related Problems in a Pediatric Bone Marrow Transplantation Unit Identified by a Clinical Pharmacist in-training in a 7-Month PeriodOzdemir N., ÇELİKER A., KUŞKONMAZ B. B., OKUR F. V., Cetinkaya D. U.CLINICAL AND EXPERIMENTAL HEALTH SCIENCES, cilt.10, sa.1, ss.21-26, 2020 (ESCI, TRDizin)
  23. Coping and psychopathology in children with malignancy and bronchiectasisBIKMAZER A., ÖRENGÜL A. C., Buyukdeniz A., OKUR F. V., GÖKDEMİR Y., PERDAHLI FİŞ N.PEDIATRIC PULMONOLOGY, cilt.55, sa.1, ss.214-220, 2020 (SCI-Expanded, Scopus)
  24. Osteopetrotic induced pluripotent stem cells derived from patients with different disease-associated mutations by non-integrating reprogramming methodsOKUR F. V., Cevher I., ÖZDEMİR SAKA C., Kocaefe C., ÇETİNKAYA F. D.STEM CELL RESEARCH & THERAPY, cilt.10, 2019 (SCI-Expanded, Scopus)
  25. Bone marrow transplantation with Favorable outcome in three patients with LPS-responsive beige like anchor (LRBA) deficiencyOKUR F. V., KUŞKONMAZ B. B., Cagdas D. N., Tezcan I., Uckan-Cetinkaya D.CLINICAL IMMUNOLOGY, cilt.203, ss.162-165, 2019 (SCI-Expanded, Scopus)
  26. Evaluation of drugs used in paediatric bone marrow transplantation unit in terms of drug interactionsOzdemir N., Tecen K., KARA E., ÇELİKER A., OKUR F. V., KUŞKONMAZ B. B., et al.INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, cilt.40, sa.1, ss.274, 2018 (SCI-Expanded, Scopus)
  27. Clinical pharmacist's contribution on managing drug related problems in paediatric hematopoietic stem cell transplantationOzdemir N., ÇELİKER A., OKUR F. V., KUŞKONMAZ B. B., Cetinkaya D. U.INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, cilt.40, sa.1, ss.274-275, 2018 (SCI-Expanded, Scopus)
  28. Hematopoietic stem cell transplantation in children with Griscelli syndrome: A single-center experienceKuskonmaz B. B., ÇAĞDAŞ AYVAZ D. N., Gokce M., Ozgur T. T., OKUR F. V., Cetin M., et al.PEDIATRIC TRANSPLANTATION, cilt.21, sa.7, 2017 (SCI-Expanded, Scopus)
  29. Pluripotent Kök Hücreler: Embriyonik Kök Hücre ve Uyarılmış Pluripotent Kök HücreOKUR F. V.TÜRKİYE KLİNİKLERİ PŞASTİK CERRAHİ, cilt.3, sa.4, ss.7-10, 2015 (Hakemsiz Dergi)
  30. Mezenkimal Kök Hücre ve Kemik İliği MikroçevresiOKUR F. V.TÜRKİYE KLİNİKLERİ, cilt.4, sa.7, ss.19-23, 2014 (Hakemli Dergi)
  31. Acute in Vitro effects of ABS (Ankaferd Hemostat) on the Lymphoid Neoplastic Cells (B-CLL and RAJI Tumor Cell Lines)AKALIN İ., Okur F. V., HAZNEDAROĞLU İ. C., SAYINALP N., AKSU S., BÜYÜKAŞIK Y., et al.UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, cilt.24, sa.4, ss.253-259, 2014 (SCI-Expanded, Scopus, TRDizin)
  32. Comparison of two CD40-ligand/interleukin-2 vaccines in patients with chronic lymphocytic leukemia.Okur F. V., YVON E., BIAGI E., DOTTI G., CARRUM G., HESLOP H., et al.Cytotherapy, cilt.13, ss.1128-39, 2011 (SCI-Expanded, Scopus)
  33. Clinical significance of serum vascular endothelial growth factor, endostatin, and leptin levels in children with lymphoma.Okur F. V., KARADENIZ C., BUYUKPAMUKCU M., OGUZ A., YUCEL A., CINAZ P., et al.Pediatric blood & cancer, cilt.55, ss.1272-7, 2010 (SCI-Expanded, Scopus)
  34. Stem Cell Transplantation in Childhood Non-Hodgkin's LymphomasOkur F. V., KRANCE R.CURRENT HEMATOLOGIC MALIGNANCY REPORTS, cilt.5, sa.4, ss.192-199, 2010 (SCI-Expanded, Scopus)
  35. Cellular immunotherapy of cancer.Okur F. V., BRENNER M.Methods in molecular biology (Clifton, N.J.), cilt.651, ss.319-45, 2010 (Scopus)
  36. Overview of gene therapy clinical progress including cancer treatment with gene modified T cellsBrenner M., OKUR F. V.Hematology-American Society of Hematology Education Program, cilt.2009, sa.1, ss.675-681, 2009 (Scopus)
  37. Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regression.FOSTER A., Okur F. V., BIAGI E., LU A., DOTTI G., YVON E., et al.Molecular cancer, cilt.8, ss.106, 2009 (SCI-Expanded, Scopus)
  38. Evaluation of peripheral lymphadenopathy in childrenOGUZ A., KARADENIZ C., TEMEL E. A., CITAK E. C., Okur F. V.PEDIATRIC HEMATOLOGY AND ONCOLOGY, cilt.23, sa.7, ss.549-561, 2006 (SCI-Expanded, Scopus)

Conference papers 50

  1. Are transfusion reactions associated with hematopoietic stem cell product infusion more frequent than previously thought?Apak F. B. B., OKUR F. V., Cetin N., Balkan M., Warasnhe K., KUŞKONMAZ B. B., et al.30th International Congress of The Transplantation-Society (TTS), İstanbul, Türkiye, 22 - 25 Eylül 2024, ss.492, (Özet Bildiri)
  2. EXPERIENCES OF PARENTS WHO CONCEIVED SAVIOR SIBLINGS FOR BEING HEMATOPOIETIC STEM CELL DONORS TO THEIR SICK CHILDREN AND SUCCESSFULLY COMPLETED THE PROCESS: A QUALITATIVE STUDYEker I., Ozdemir H. N. C., Yilmaz F., Yesilipek A., Kupesiz A., Uygun V., et al.49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, ELECTR NETWORK, 23 - 26 Nisan 2023, ss.600-601, (Özet Bildiri)
  3. ANALYSIS OF LATE RENAL COMPLICATIONS AND RISK FACTORS IN CHILDREN WITH HEMATOPOIETIC STEM CELL TRANSPLANTATIONGurbanov A., GÜLHAN B., KUŞKONMAZ B. B., OKUR F. V., Cetinkaya D. U., Ozdemir G., et al.57th ERA-EDTA Congress, ELECTR NETWORK, 6 - 09 Haziran 2020, cilt.35, ss.2140, (Özet Bildiri)
  4. EARLY URINARY SYSTEM COMPLICATIONS IN CHILDREN WITH HEMATOPOIETIC STEM CELL TRANSPLANTATIONGurbanov A., GÜLHAN B., KUŞKONMAZ B. B., OKUR F. V., Cetinkaya D. U., Ozdemir G., et al.57th ERA-EDTA Congress, ELECTR NETWORK, 6 - 09 Haziran 2020, cilt.35, ss.2123, (Özet Bildiri)
  5. Pre-Transplant Angiopoietin Index Predicts the Development of Graft Versus Host Disease after Allogeneic Hematopoietic Stem Cell TransplantationCimen O., Cevher I., Alkan B., KARAKAYA KARABULUT J., Cetinkaya D., OKUR F. V.Transplantation and Cellular Therapy (TCT) Meetings of ASTCT and CIBMTR, Florida, Amerika Birleşik Devletleri, 19 - 23 Şubat 2020, cilt.26, (Özet Bildiri)
  6. Modeling Hematopoietic Niche in Osteopetrosis Using Patient-Derived Induced Pluripotent Stem Cellscevher i., Alkan B., ÖZDEMİR SAKA C., ÇETİNKAYA F. D., OKUR F. V.ESGCT, Barcelona, İspanya, 22 - 25 Ekim 2019, (Özet Bildiri)
  7. Differentiation of Osteopetrotic IPSCs Towards Osteoclasts: Comparision of Osteopetrotic and Healthy OsteoclastsCEVHER I., ALKAN B., ÇETİNKAYA F. D., OKUR F. V.27th BCLF and 30th TBS, 27 - 31 Ekim 2019, (Özet Bildiri)
  8. Niş benzeri kokültür sistemi ile AML lösemik kök hücrelerin tanımlanması ve karekterizasyonuAlkan B., Cevher I., GÜLBAKAN B., AYTAC Ş. S., CETINKAYA D., OKUR F. V.45. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 30 Ekim - 02 Kasım 2019, (Tam Metin Bildiri)
  9. Successful hematopoietic stem cell transplantation in a child with CD40 deficiencyKUŞKONMAZ B. B., ÇAĞDAŞ AYVAZ D. N., OKUR F. V., BARIŞ S., TEZCAN F. İ., UÇKAN ÇETİNMKAYA D.Meeting of the European Society for Immunodeficiencies, Brussels, Belgium, September 18-21, 2019, 18 - 21 Eylül 2019
  10. Succesful bone marrow transplantation from HLA 9/10 matched relative after myeloablative conditioning in a patient with PRKDC defectKuskonmaz B. B., Cagdas D. N., OKUR F. V., Tezcan I., DEMİR H., ÇETİNKAYA F. D.ESID, Brüksel, Belçika, 18 - 21 Eylül 2019, (Özet Bildiri)
  11. Studies on Induced Pluripotent Stem Cell (iPSC) Banking in TurkeyAYGAR S., CEVHER I., ALKAN B., KILIC E., BAYRAKTAR K., OKUR F. V., et al.3rd International Congress on Advances in Bioscience and Biotechnology (ICABB), 10 - 14 Temmuz 2019, (Özet Bildiri)
  12. Hematopoetik Kök Hücre Nakli Yapılan Çocuk Hastalarda Erken Dönem Üriner Sistem KomplikasyonlarıGurbanov A., GÜLHAN B., KUŞKONMAZ B. B., OKUR F. V., Uçkan Çetinkaya D., Özdemir G., et al.10. Çocuk Nefrolojisi Kongresi, Türkiye, 1 - 04 Mayıs 2019, (Özet Bildiri)
  13. Hematopoetik Kök Hücre Nakli Yapılan Çocuk Hastalarda Geç Dönem Renal Komplikasyonların Ve RiskFaktörlerinin AnaliziGurbanov A., GÜLHAN B., KUŞKONMAZ B. B., OKUR F. V., Uçkan Çetinkaya D., Özdemir G., et al.10. Çocuk Nefrolojisi Kongresi, Türkiye, 1 - 04 Mayıs 2019, (Özet Bildiri)
  14. Hematopoietic differentiation potential of induced pluripotent stem cells derived from osteopetrosis patients’xx peripheral blood mononuclear cellsCevher I., Alkan B., Ozdemir C., CETINKAYA D., OKUR F. V.ISSCR International Symposia, Amsterdam, Hollanda, 20 - 22 Şubat 2019, (Özet Bildiri)
  15. Relapse after allogeneic hematopoietic stem cell transplantation for acute leukemia in children: a survey by the Turkish Pediatric Bone Marrow Transplantation Study Group of 255 casesHAZAR V., TEZCAN KARASU G., ÖZTÜRK H. G., KÜPESİZ O. A., KANSOY S., ÖZBEK N., et al.The 44th Annual Meeteng of the European Society for Blood and Marrow Transplantation, 18 - 21 Mart 2018, (Tam Metin Bildiri)
  16. RELAPS AKUT LÖSEMİSİ OLAN PEDİATRİK OLGULARDAİKİNCİ HEMATOPOİETİK KÖK HÜCRE NAKİL SONUÇLARIHAZAR V., KARASU G., UYGUN V., ÖZBEK N. Y., KARAKÜKCÜ M., ÖZTÜRK H. G., et al.44.ULUSAL HEMATOLOJİ KONGRESİ, Türkiye, 31 Ekim - 03 Kasım 2018, ss.195, (Tam Metin Bildiri)
  17. Malignite ve BronşektaziliÇocuklarda Başa Çıkma ve PsikopatolojiBIKMAZER A., Orengul C., Büyükaslan A., GÖKDEMİR Y., OKUR F. V., KARADAĞ B. T., et al.Çocuk Göğüs Hastalıkları 3. Kongresi, İstanbul, Türkiye, 26 - 28 Eylül 2018, ss.102, (Özet Bildiri)
  18. Extracorporeal Photopheresis for Graft versus Host Disease in Pediatric Patients: A Pilot Single Institution ReportOKUR F. V., KUŞKONMAZ B. B., Cetin N., Demirsu A., TAŞDEMİR O. A., Cetinkaya D. U.44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portekiz, 18 - 21 Mart 2018, cilt.53, ss.414-415, (Özet Bildiri)
  19. Relapse after allogeneic hematopoietic stem cell transplantation for acute leukemia in children: a survey by the Turkish Pediatric Bone Marrow Study Group of 255 casesHazar V., Karasu G. T., Ozturk G., Kupesiz A., KANSOY S., Ozbek N., et al.44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portekiz, 18 - 21 Mart 2018, cilt.53, ss.182-183, (Özet Bildiri)
  20. Successful Hematopoetic Stem Cell Transplantation with Non-Myeloablative conditioning in a patient with Primary Pulmonary Alveolar ProteinosisOzcelik U., Aytac Ş. S., KUŞKONMAZ B. B., Yalcin E., Ersoz D. D., Okur V., et al.44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portekiz, 18 - 21 Mart 2018, cilt.53, ss.723, (Özet Bildiri)
  21. Leucoderma and leucotrichia in association with chronic cutaneous graft-versus-host disease in a child with Wiskott-Aldrich syndromeKUŞKONMAZ B. B., OKUR F. V., Cetin N., Teker S., Cetinkaya D. U.44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portekiz, 18 - 21 Mart 2018, cilt.53, ss.707-708, (Özet Bildiri)
  22. Hematopoietic stem cell transplantation in childrenwith Wiskott-Aldrich syndrome with myeloablativeconditioningKUŞKONMAZ B. B., OKUR F. V., ÇAĞDAŞ AYVAZ D. N., AYTAÇ EYÜPOĞLU Ş. S., TEZCAN F. İ., ÇETİNKAYA F. D.The 44th Annual Meeting of the European Society for Blood and Marrow Transplantation. 18–21 March 2018. Lisbon, Portugal, 18 - 21 Mart 2018, (Özet Bildiri)
  23. Relapse after allogeneic hematopoietic stem cell transplantation for acute leukemıa in children: a survey by theTurkish pediatricbone marrow study group of 225 cases.HAZAR V., TEZCAN G., ÖZTÜRK G., KÜPESİZ O. A., KANSOY S., ÖZBEK N. Y., et al.44th EBMT Annual Meeting, Lisbon, PORTEKİZ., LİZBON, Portekiz, 18 - 21 Mart 2018, cilt.1, ss.135, (Tam Metin Bildiri)
  24. Akut lösemili çocuklarda allojenik hematopoetik kök hücre nakli sonrasındarelpsda tedavi yaklaşımlarıHAZAR V., KARASU G., öztürk G., KÜPESİZ O. A., KANSOY S., özbek n., et al.10. ulusal kemik iliği transplantasyonu ve hücresel tedaviler kongresi, 1 - 03 Mart 2018, (Tam Metin Bildiri)
  25. Çocuklarda Hematopoetik Kök Hücre Nakli Sonrası Prognozu Belirlemede Modifiye Ebmt Risk Skorlamasının KullanımıGEZGEN KESEN G., POTAS KAYA N., OKUR F. V., OK BOZKAYA İ., AKSU T., KUŞKONMAZ B. B., et al.10. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 1 - 03 Mart 2018, (Özet Bildiri)
  26. Çocuklarda Hematopoietik Kök Hücre Nakli Sonrası Prognozun Belirlenmesinde Modifiye EBMT Skorlamasının KullanımıOKUR F. V., Kuskonmaz B. B., ÇETİNKAYA F. D., Aksu T., Ozbek N.10. THD Ulusal Kemik İliği Transplantasyonu ve Hücresel, Türkiye, 1 - 03 Mart 2018, (Tam Metin Bildiri)
  27. Tyrosine Kinase Inhibitor Responses in Pediatric CML Patients: Hacettepe ExperienceYAMAN BAJİN H. İ., AYTAÇ EYÜPOĞLU Ş. S., KUŞKONMAZ B. B., ÜNAL CANGÜL Ş., OKUR F. V., ÇETİNKAYA F. D., et al.49th Congress of the International Society of Paediatric Oncology (SIOP) Washington, DC, USA October 12–15, 2017, Washington, Kiribati, 12 - 15 Ekim 2017, cilt.64, ss.202, (Özet Bildiri)
  28. Childhood leukemia in an ETV6-related Thrombocytopenia family.YAMAN BAJİN H. İ., AYTAÇ EYÜPOĞLU Ş. S., KUŞKONMAZ B. B., ÜNAL CANGÜL Ş., OKUR F. V., ÇETİNKAYA F. D., et al.49th Congress of the International Society of Pediatric Oncology (SIOP), Washington, Kiribati, 12 - 15 Ekim 2017, cilt.64, ss.192, (Özet Bildiri)
  29. Clinical Pharmacists’ Contribution On Managing Drug Related Problems In Paediatric Hematopoietic Stem Cell TransplantationÖZDEMİR N., ÇELİKER A., OKUR F. V., KUŞKONMAZ B. B., ÇETİNKAYA F. D.46th ESCP Symposium On Clinical Pharmacy, 9 - 11 Ekim 2017, (Özet Bildiri)
  30. Evaluation Of Drugs Used İn Paediatric Bone Marrow Transplantation Unit In Terms Of Drıg İnteractionsÖZDEMİR N., TECEN YÜCEL K., KARA E., ÇELİKER A., OKUR F. V., KUŞKONMAZ B. B., et al.46th ESCP Symposium on Clinical Pharmacy, Heidelberg, Almanya, 9 - 11 Ekim 2017, (Özet Bildiri)
  31. Remission after allogeneic hematopoietic stem celltransplantation in a patient with LPS-responsive beige-likeanchor (LRBA) gene mutationOKUR F. V., KUŞKONMAZ B. B., ÇAĞDAŞ AYVAZ D. N., aksu T., ÇETİN M., TEZCAN F. İ., et al.43rd Annual Meeting of the European Society forBlood and Marrow Transplantation, 26 - 29 Mart 2017, (Özet Bildiri)
  32. Successful bone marrow transplantation aftermyeloablative conditioning in a child with IPEX syndromeKUŞKONMAZ B. B., ÇAĞDAŞ AYVAZ D. N., ABUR M., OKUR F. V., KARAGÜZEL G., ORHAN F., et al.43rd Annual Meeting of the European Society forBlood and Marrow Transplantation, 26 Mart - 22 Aralık 2017, (Özet Bildiri)
  33. Remission after allogeneic hematopoietic stem cell transplantation in a patient with LPS‐responsivebeige‐like anchor (LRBA) gene mutationOKUR F. V., KUŞKONMAZ B. B., ÇAĞDAŞ AYVAZ D. N., aksu T., ÇETİN M., TEZCAN F. İ., et al.EBMT 2017, 26 - 29 Mart 2017, (Tam Metin Bildiri)
  34. Successful bone marrow transplantation after myeloablative conditioning in a child with IPEX syndromeKUŞKONMAZ B. B., ÇAĞDAŞ AYVAZ D. N., haktanır abul m., OKUR F. V., KARAGÜZEL G., ORHAN F., et al.EBMT 2017, 26 - 29 Mart 2017, (Tam Metin Bildiri)
  35. Pediatrik Kemik İliği Nakli Ünitesinde Kullanılan İlaçların İlaç Etkileşimleri Açısından DeğerlendirilmesiÖZDEMİR N., TECEN YÜCEL K., KARA E., ÇELİKER A., OKUR F. V., KUŞKONMAZ B. B., et al.3. Ulusal Klinik Eczacılık Farmasötik Bakım Kongresi, Antalya, Türkiye, 9 - 12 Şubat 2017, (Özet Bildiri)
  36. Pediatrik Kemik İliği Nakil Ünitesinde Kullanılan İlaçların İlaç Etkileşimleri Açısından DeğerlendirilmesiÖZDEMİR N., TECEN YÜCEL K., KARA E., ÇELİKER A., OKUR F. V., KUŞKONMAZ B. B., et al.3. Ulusal Klinik Eczacılık Farmasötik Bakım Kongresi, Türkiye, 9 - 12 Şubat 2017, (Özet Bildiri)
  37. Generation of induced pluripotent stem cells from human mesenchymal stem cells by sendai virus vectorsPEHLİVANOĞLU S., INCI C., EMINE K., ÇELEBİ SALTIK B., ÇETİNKAYA F. D., OKUR F. V.Sanko University Innovation in Medicine Summit-2, 5 - 07 Mayıs 2016, (Özet Bildiri)
  38. Pediatrik hematopoietik kök hücre nakli sonrasında görülen dirençli sitopenilerin rituksimab ile tedavi sonuçlarıAKSU T., KUŞKONMAZ B. B., OKUR F. V., ÜNAL CANGÜL Ş., ÇETİNKAYA F. D.9. Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavileri Kongresi, 03 Mart 2016, (Özet Bildiri)
  39. Favorable Response to Rituximab in Refractory Cytopenias Occurring After Pediatric Hematopoietic Stem Cell TransplantationAKSU T., KUŞKONMAZ B. B., OKUR F. V., ÜNAL S., Cetinkaya D. U.42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Valencia, İspanya, 3 - 06 Nisan 2016, cilt.51, (Özet Bildiri)
  40. Generation of integration free human IPS cells from mesenchymal stem cellsCEVHER I., PEHLİVANOĞLU S., KILIÇ E., ÇELEBİ SALTIK B., ÇETİNKAYA F. D., OKUR F. V.2nd International Congress on Stem Cell and Cellular Therapies, 15 - 17 Kasım 2015, (Özet Bildiri)
  41. HEMATOPOIETIC STEM CELL TRANSPLANTATION IN FANCONI ANEMIAOKUR F. V.6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
  42. Split Chimerism Between Nucleated and Red Blood Cells in a Beta Thalassemia Patient After Stem Cell TransplantationOKUR F. V., Aerts-Kaya F. S. F., KUŞKONMAZ B. B., OKUR H., ÇETİN M., GÜMRÜK F., et al.41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50, (Özet Bildiri)
  43. NURSE TRAINING PROGRAM ADJUSTED FOR PEDIATRIC HSCT FOCUSING ON SPECIAL ISSUES IN INHERITED DISEASESCetin N., KIRAÇ F., Ozenc F., OKUR F. V., KUŞKONMAZ B. B., Uckan-Cetinkaya D.41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50, ss.5527-5528, (Özet Bildiri)
  44. Association Between High Uric Acid Levels and Hepatic Veno-Occlusive Disease in HCSTKarapapak M., OKUR F. V., KUŞKONMAZ B. B., ÇETİN M., Uckan-Cetinkaya D.41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50, (Özet Bildiri)
  45. UNDERSTANDING AND MANAGEMENT OF DISEASE SPECIFIC COMPLICATIONS BY HSCT NURSES IN MALIGNANT INFANTILE OSTEOPETROSIS DURING THE COURSE OF HSCTCetin N., KIRAÇ F., Kucukyavuz E., Tavil B., OKUR F. V., KUŞKONMAZ B. B., et al.41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50, ss.5526-5527, (Özet Bildiri)
  46. Successful bone marrow transplantation from HLA 9/10 matched relative after myeloablative conditioning in a patient with PRKDC defectKUŞKONMAZ B. B., ÇAĞDAŞ AYVAZ D. N., OKUR F. V., DEMİR H., TEZCAN F. İ., ÇETİNKAYA F. D.
  47. GENERATION OF INDUCED PLURIPOTENT STEM CELLS FROMMESENCHYMAL STEM CELLS OF OSTEOPETROSIS PATIENTSBY TWO DIFFERENT INTEGRATION-FREE METHODS UNDERFEEDER-FREE CONDITIONSOKUR F. V., CEVHER İ., KILIÇ E., ÖZDEMİR SAKA C., KOCAEFE Y. Ç., ÇETİNKAYA F. D.
  48. Hematopoietic stem cell transplantation in children with Wiskott-Aldrich syndrome with myeloablative conditioningKUŞKONMAZ B. B., OKUR F. V., ÇAĞDAŞ AYVAZ D. N., AYTAÇ EYÜPOĞLU Ş. S., TEZCAN F. İ., ÇETİNKAYA F. D.
  49. Reprogramming of human mesenchymal stem cells from healthy donors and patients with osteopetrosis with non integrating RNA virus on feeder free conditionsOKUR F. V., CEVHER İ., kilic e., pehlivanoglu s., uckancetinkaya d., celebi saltık B.
  50. Effects of chimeric antigen receptor ( CAR) expression on regulatory T cellsAkalin I., Perna S., Biagio D. A., OKUR F. V., Rooney C., Heslop H., et al.

Contact

Department
Pediatric Hematology, Children's Hospital

Last updated: